Search  
Friday, September 03, 2010 ..:: News (RSS Feeds) ::.. Register  Login
Insider Health Information Resveratrol article at LifeExtension.com

 Interesting Links Minimize

    

   Minimize

HOME

NEWS

ImmortalityOnline Blogs
Aging Research
Artificial Intelligence
Cryonics
Longevity

 


      

 Living Longer - the FACTS (courtesy of Yahoo News RSS) Minimize

To Lengthen Men’s Lives, Focus on Guns
Homicides, rising again, remain a crucial factor in New York City’s life-expectancy gender gap.

Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
CORK, Ireland, September 3, 2010 /PRNewswire/ -- Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once ...

Benefits seen in ovary removal for high-risk women
CHICAGO - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.

Meals On Wheels Can't Meet Demand For Food
SEMINOLE COUNTY, Fla. -- There is a staggering new demand for food for elderly people in Central Florida. Requests for help from Meals on Wheels in Seminole County are up more than 1,000 percent in the past five years and there aren't enough meals to go around.

New study validates preventive mastectomies
Surgeries found to improve chances of patient living longer.

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency
Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in ...

Study: Ovary removal benefits high-risk women
CHICAGO #8212; Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer and boosts their chances of living longer, new research suggests.

Auckland residents living longer
Auckland City residents seem to be living longer but Maori and Pacific people die younger.The State of the City report has just been released by the Auckland City Council.It covers economic, social, environmental and cultural...

Benefits seen for high-risk women in ovary removal
Those with gene mutation boost odds of living longer

Will Nest leave the Coalition with egg on its face over pension savings?
In the coming weeks, the new Coalition Government faces some stark choices on pensions, relating to tax relief for high earners, public sector pensions and the implementation of a new pensions system for the UK.

    

 <a href="http://www.superiorpapers.com">buy essay online</a>


buy essay online
Copyright 2006 by Immortality International, Inc.   Terms Of Use  Privacy Statement
DotNetNuke® is copyright 2002-2010 by Perpetual Motion Interactive Systems Inc.